We are live on ! Find out more
XGN icon

Exagen
XGN

31 hedge funds and large institutions have $16.5M invested in Exagen in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,400% more call options, than puts

Call options by funds: $170K | Put options by funds: $2K

6.27% less ownership

Funds ownership: 48.77% → 42.5% (-6.3%)

18% less funds holding

Funds holding: 38 → 31 (-7)

23% less capital invested

Capital invested by funds: $21.4M → $16.5M (-$4.96M)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

74% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 19

Holders
31
Holders Change
-7
Holders Change %
-18.42%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
19
Closed
10
Calls
$170K
Puts
$2K
Net Calls
+$168K
Net Calls Change
-$318K

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$810K
2
CS
Credit Suisse
Switzerland
+$12.8K
3
TRCT
Tower Research Capital (TRC)
New York
+$3.7K
4
Wells Fargo
Wells Fargo
California
+$2.57K
5
Simplex Trading
Simplex Trading
Illinois
+$1.4K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$1.06M
2
CAC
Cowen and Company
New York
-$932K
3
BCI
Brinker Capital Investments
Pennsylvania
-$269K
4
PIM
Platinum Investment Management
Australia
-$223K
5
PCMI
Paradigm Capital Management Inc
New York
-$220K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$4K +$3.7K +1,441 +4,117%
Osaic Holdings
27
Osaic Holdings
Arizona
$2K -$11.6K -4,522 -87%
Simplex Trading
28
Simplex Trading
Illinois
$1K +$1.4K +547 New
NA
29
NewEdge Advisors
Louisiana
$588 +$628 +245 New
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$157 -$13.5K -5,254 -7%
BCI
31
Brinker Capital Investments
Pennsylvania
– -$269K -99,115 Closed
PCMI
32
Paradigm Capital Management Inc
New York
– -$220K -81,189 Closed
ACM
33
Advisors Capital Management
New Jersey
– -$143K -67,923 Closed
Deutsche Bank
34
Deutsche Bank
Germany
– -$137K -50,660 Closed
E
35
Ergoteles
New York
– -$132K -48,558 Closed
Envestnet Asset Management
36
Envestnet Asset Management
Illinois
– -$64K -23,665 Closed
PA
37
Parallel Advisors
California
– -$11K -4,213 Closed
FHA
38
First Horizon Advisors
Tennessee
– -$3K -1,378 Closed
CPA
39
Cowen Prime Advisors
New York
– -$1K -500 Closed
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
– -$458 -169 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– -$156 -61 -27%
1
2

XGN Hedge Fund Activity: Q4 2022 in Review

31 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q4 2022, worth a combined $16.5M — down 23% from $21.4M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of XGN and 3 opened new positions — a net loss of 7 holders — while 19 trimmed existing stakes and 5 added.

The largest buyer was RTW Investments, adding an estimated $810K. The largest seller was Stonepine Capital Management, cutting an estimated $1.06M.

  • 31 institutional investors held Exagen (XGN) as of Q4 2022, down from 38 in Q3 2022.
  • Funds reported $16.5M of Exagen stock for Q4 2022, down 23% quarter-over-quarter.
  • 3 funds opened new Exagen positions in Q4 2022 and 10 closed out, a net change of -7 holders.
  • The largest Exagen buyer in Q4 2022 was RTW Investments, an estimated $810K added.
  • The largest Exagen seller in Q4 2022 was Stonepine Capital Management, an estimated $1.06M sold.

Based on aggregated 13F filings for Q4 2022.